MANGANESE PHOSPHATE, DIBASIC

First marketed in 1921

Details

Stereochemistry	ACHIRAL
Molecular Formula	Mn.HO4P
Molecular Weight	150.9173
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of MANGANESE PHOSPHATE, DIBASIC

Structure Search

SMILES

[Mn++].OP([O-])([O-])=O

InChI

InChIKey=CPSYWNLKRDURMG-UHFFFAOYSA-L

InChI=1S/Mn.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+2;/p-2

HIDE SMILES / InChI

Description
Sources: https://www.alfa.com/en/catalog/032808/https://www.ncbi.nlm.nih.gov/pubmed/6658791https://www.ncbi.nlm.nih.gov/pubmed/3725729 | https://www.ncbi.nlm.nih.gov/pubmed/3989083 | https://www.ncbi.nlm.nih.gov/pubmed/25464291 | https://www.ncbi.nlm.nih.gov/pubmed/20934746https://google.com/patents/CN104529454A?http://pubs.acs.org/doi/pdfplus/10.1021/jo970656jhttps://www.drugs.com/pro/manganese-sulfate-injection.htmlhttp://www.druginfosys.com/drug.aspx?drugcode=2295&type=1https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=184 | https://www.ncbi.nlm.nih.gov/pubmed/24861367
Curator's Comment: description was created based on several sources, including https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260883.htm

Manganese citrate is generally recognized as safe direct food additive. Manganese citrate complex has being used in the determination of liver enzyme activities in the aging process and following treatment with aminoethylisothiuronium bromide hydrobromide (AET).

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Arginase-1 25 Target ID: CHEMBL1075097 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19032027	Activator 1430
Arginase-2, mitochondrial 24 Target ID: CHEMBL1795148 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25974698	Activator 1430
Glutamine synthetase 29 Target ID: CHEMBL4612 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25974698	Activator 1430

Conditions

Condition	Modality	Highest Phase	Product
Unknown 2578
Unknown 2578
Unknown 2578
Cancer 592 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20934746	Primary	Basic research	Unknown Approved Use Unknown
Manganese deficiency 27 Sources: http://www.webmd.com/vitamins-supplements/ingredientmono-182-manganese.aspx?activeingredientid=182&	Primary	Approved 8429	Unknown Approved Use Manganese is used for prevention and treatment of manganese deficiency, a condition in which the body doesn’t have enough manganese.
Osteoporosis 97 Sources: http://www.webmd.com/vitamins-supplements/ingredientmono-182-manganese.aspx?activeingredientid=182&	Primary	Approved 8429	Unknown Approved Use Manganese is used for weak bones (osteoporosis).
Premenstrual syndrome 37 Sources: http://www.webmd.com/vitamins-supplements/ingredientmono-182-manganese.aspx?activeingredientid=182&	Palliative	Approved 8429	Unknown Approved Use Early research suggests that taking manganese along with calcium helps improve symptoms of PMS, including pain, crying, loneliness, anxiety, restlessness, irritability, mood swings, depression, and tension.
Manganese deficiency 27 Sources: https://www.drugs.com/pro/manganese-sulfate-injection.html	Curative	Approved 8429	MANGANESE SULFATE Approved Use Manganese Sulfate Injection, USP is indicated for use as a supplement to intravenous solutions given for Total Parenteral Nutrition (TPN). Administration helps to maintain plasma levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Unknown 2578
Unknown 2578
Gastrointestinal disorders 95 Sources: https://www.drugs.com/cdi/magnesium-sulfate.html	Primary	Approved 8429	MANGANESE SULFATE Approved Use Unknown

PubMed

Title	Date	PubMed
Effect of fluoride on copper, manganese and zinc in bone and kidney.	1981 Mar	7284642
Effect of quantity and route of administration of manganese monoxide on feed intake and serum manganese in ruminants.	1985 Feb	3989083
Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure.	1993 Jul	8243401
Equilibrium and kinetics studies of reactions of manganese acetate, cobalt acetate, and bromide salts in acetic acid solutions.	2001 Jun 18	11399197
Is the axial zero-field splitting parameter of tetragonally elongated high-spin manganese(III) complexes always negative?	2002 Jul 31	12137507
Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrin.	2003 Jan	12564377
Bi- and poly-metallic cyanide-bridged complexes of the redox-active cyanomanganese nitrosyl unit [Mn(CN)(PR3)(NO)(eta-C5H4Me)].	2004 Feb 21	15252534
Decreased expression of inflammation-related genes following inhalation exposure to manganese.	2006 May	16476481
CsR(R(6)CoI(12))2 (R = Gd, Er) and (CeI)0.26(Ce(6)MnI(9))2: two new structure types featuring R(6)Z clusters.	2006 Nov 27	17112265
Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity.	2007 Jun	17347134
Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain.	2009 Sep	19520674
Controlled Synthesis of Hollow Manganese Oxide Nanocrystals.	2016 Feb	27433689
Intramolecular Aminoalkoxylation of Unfunctionalized Olefins via Intramolecular Iodoamination and Aziridinium Ion Ring-Opening Sequence.	2017 Apr 7	28333470

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Name

Type

Language

MANGANESE PHOSPHATE, DIBASIC

Common Name

English

MANGANESE PHOSPHATE DIBASIC

Common Name

English

MANGANESE PHOSPHATE

Systematic Name

English

Manganese phosphate dibasic [WHO-DD]

Common Name

English

MANGANUM PHOSPHORICUM [HPUS]

Common Name

English

MANGANUM PHOSPHORICUM

Common Name

English

MANGANESE PHOSPHATE, DIBASIC [MI]

Common Name

English

Code System Code Type Description

SMS_ID

100000076507